Cargando…
Histone methyltransferase Smyd2 drives vascular aging by its enhancer-dependent activity
Background: Vascular aging is one of the important factors contributing to the pathogenesis of cardiovascular diseases. However, the systematic epigenetic regulatory mechanisms during vascular aging are still unclear. Histone methyltransferase SET and MYND domain-containing protein 2 (Smyd2) is asso...
Autores principales: | Su, Zhenghua, Su, Haibi, Xu, Jie, Wei, Gang, Qu, Lefeng, Ni, Ting, Yang, Di, Zhu, Yizhun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9876634/ https://www.ncbi.nlm.nih.gov/pubmed/36585926 http://dx.doi.org/10.18632/aging.204449 |
Ejemplares similares
-
Histone methyltransferase Smyd2 drives adipogenesis via regulating STAT3 phosphorylation
por: Su, Haibi, et al.
Publicado: (2022) -
Histone methyltransferase Smyd2 contributes to blood‐brain barrier breakdown in stroke
por: Wang, Jinghuan, et al.
Publicado: (2022) -
Histone methyltransferase Smyd3 is a new regulator for vascular senescence
por: Yang, Di, et al.
Publicado: (2020) -
The histone methyltransferase DOT1L is a new epigenetic regulator of pulmonary fibrosis
por: Yang, Di, et al.
Publicado: (2022) -
Correction: The histone methyltransferase DOT1L is a new epigenetic regulator of pulmonary fibrosis
por: Yang, Di, et al.
Publicado: (2022)